Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesJennifer L. Crombie, Nicolas C. Issa, Rebecca L. Zon et al.|Blood Advances|2021Cited by 24
Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and ReactogenicityAmy C Sherman, Lindsey R. Baden, Michaël Desjardins et al.|Clinical Infectious Diseases|2021Cited by 24